Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning

Carolina Garcia-Vidal; Catia Cillóniz; Antoni Torres

doi:10.1183/13993003.02111-2019

Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning

Carolina Garcia-Vidal, Catia Cillóniz, Antoni Torres

Producción científica: Artículo Científico › Editorial

1 Cita (Scopus)

Idioma original	Inglés estadounidense
-	1902111
Publicación	European Respiratory Journal
Volumen	54
N.º	6
DOI	https://doi.org/10.1183/13993003.02111-2019
Estado	Indizado - 1 dic. 2019
Publicado de forma externa	Sí

Acceder al documento

10.1183/13993003.02111-2019

Citar esto

@article{75a05ed2cef44269ab8e3d18eb8b1322,

title = "Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning",

author = "Carolina Garcia-Vidal and Catia Cill{\'o}niz and Antoni Torres",

note = "Funding Information: Conflict of interest: S.F. Rahmawati has nothing to disclose. R. Gosens reports grants from Boehringer Ingelheim, Chiesi Farmaceutici and Aquilo, outside the submitted work. Funding Information: Support statement: C. Cill{\'o}niz is the recipient of a postdoctoral grant (Strategic plan for research and innovation in health; ERIS 2016-2020), the SEPAR fellowship 2018, and a grant from the Fondo de Investigaci{\'o}n Sanitaria (PI19/00207).",

year = "2019",

month = dec,

day = "1",

doi = "10.1183/13993003.02111-2019",

language = "American English",

volume = "54",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "6",

}

TY - JOUR

T1 - Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning

AU - Garcia-Vidal, Carolina

AU - Cillóniz, Catia

AU - Torres, Antoni

N1 - Funding Information: Conflict of interest: S.F. Rahmawati has nothing to disclose. R. Gosens reports grants from Boehringer Ingelheim, Chiesi Farmaceutici and Aquilo, outside the submitted work. Funding Information: Support statement: C. Cillóniz is the recipient of a postdoctoral grant (Strategic plan for research and innovation in health; ERIS 2016-2020), the SEPAR fellowship 2018, and a grant from the Fondo de Investigación Sanitaria (PI19/00207).

PY - 2019/12/1

Y1 - 2019/12/1

UR - https://www.scopus.com/pages/publications/85076394368

U2 - 10.1183/13993003.02111-2019

DO - 10.1183/13993003.02111-2019

M3 - Editorial

C2 - 31831676

AN - SCOPUS:85076394368

SN - 0903-1936

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 6

M1 - 1902111

ER -